These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27198690)

  • 41. Regulatory strategies for early device development and approval.
    Holmes DR; Geoffrion R; Hunt J; Hance RC; Leon MB; Mack MJ; Kaplan AV
    Catheter Cardiovasc Interv; 2022 May; 99(6):1784-1788. PubMed ID: 35485732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges related to development of bioabsorbable vascular stents.
    Berglund J; Guo Y; Wilcox JN
    EuroIntervention; 2009 Dec; 5 Suppl F():F72-9. PubMed ID: 22100681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical device regulatory landscape: the imperative of finding balance.
    Kaplan AV; Williams DO
    Circ Cardiovasc Interv; 2012 Feb; 5(1):2-5. PubMed ID: 22337999
    [No Abstract]   [Full Text] [Related]  

  • 44. ABC's of bioabsorption: application of lactide based polymers in fully resorbable cardiovascular stents.
    van Alst M; Eenink MJ; Kruft MA; van Tuil R
    EuroIntervention; 2009 Dec; 5 Suppl F():F23-7. PubMed ID: 22100672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient selection for endovascular sac sealing of abdominal aortic aneurysm.
    Fisher RK; Torella F; England A; McWilliams RG
    Semin Vasc Surg; 2016 Sep; 29(3):93-101. PubMed ID: 27989321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standard endovascular treatment of abdominal aortic aneurysms in patients with very short proximal necks using the Endurant stent graft.
    Matsagkas M; Kouvelos G; Peroulis M; Avgos S; Arnaoutoglou E; Papa N; Papadopoulos G
    J Vasc Surg; 2015 Jan; 61(1):9-15. PubMed ID: 25124361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The past, present, and future of bioresorbable vascular scaffolds.
    Taylor J
    Eur Heart J; 2014 Mar; 35(12):745-6. PubMed ID: 24659189
    [No Abstract]   [Full Text] [Related]  

  • 48. Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016.
    Fajadet J; Haude M; Joner M; Koolen J; Lee M; Tölg R; Waksman R
    EuroIntervention; 2016 Sep; 12(7):828-33. PubMed ID: 27639734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endovascular abdominal aortic aneurysm (AAA) repair since the FDA approval. Are we going too far?
    Adelman MA; Rockman CB; Lamparello PJ; Jacobowitz GR; Tuerff S; Gagne PJ; Nalbandian M; Weisswasser J; Landis R; Rosen RJ; Riles TS
    J Cardiovasc Surg (Torino); 2002 Jun; 43(3):359-67. PubMed ID: 12055568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving proximal fixation and seal with the HeliFx Aortic EndoAnchor.
    Deaton DH
    Semin Vasc Surg; 2012 Dec; 25(4):187-92. PubMed ID: 23206564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current debate on the role of embolic protection devices.
    Bornak A; Milner R
    Vasc Endovascular Surg; 2012 Aug; 46(6):441-6. PubMed ID: 22723261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Debate: whether fenestrated endografts should be limited to a small number of specialized centers.
    Haulon S; Barillà D; Tyrrell M; Tsilimparis N; Ricotta JJ
    J Vasc Surg; 2013 Mar; 57(3):875-82. PubMed ID: 23446130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invited commentary.
    Mastracci TM
    J Vasc Surg; 2011 May; 53(5):1437-8. PubMed ID: 21575758
    [No Abstract]   [Full Text] [Related]  

  • 54. Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?
    Cortese B; Buccheri D
    Int J Cardiol; 2016 Dec; 224():335-336. PubMed ID: 27668707
    [No Abstract]   [Full Text] [Related]  

  • 55. Current role and future directions of hybrid repair of thoracoabdominal aortic aneurysms.
    Oderich GS; Mendes BC; Gloviczki P; Kalra M; Duncan AA; Bower TC
    Perspect Vasc Surg Endovasc Ther; 2012 Mar; 24(1):14-22. PubMed ID: 22645173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Part Three: Open repair is the best option for type IV thoracoabdominal aortic aneurysms.
    Forbes TL
    Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):8-11. PubMed ID: 21596594
    [No Abstract]   [Full Text] [Related]  

  • 57. The saga of Poly Implant Prosthese breast implants.
    Heneghan C
    BMJ; 2012 Jan; 344():e306. PubMed ID: 22236799
    [No Abstract]   [Full Text] [Related]  

  • 58. Part One: Treatment of type IV thoracoabdominal aneurysms--hybrid technique with debranching is the best option.
    Jenkins MP
    Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):1-4. PubMed ID: 21704875
    [No Abstract]   [Full Text] [Related]  

  • 59. Endovascular repair of complex aortic aneurysms.
    Ehsan O; Murray D; Farquharson F; Serracino-Inglott F
    Ann Vasc Surg; 2011 Jul; 25(5):716-25. PubMed ID: 21724112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.